Stage FocusSeries A, Series B+
GeographyChina, US
TypeVC
Last Activity2025
Industry Focus
Industries
AIBiotechMedtechAdvanced ManufacturingIoT & Edge
Technical BenchLimited
Investor TypeGeneralist
ExposureSome DeepTech Investments
Bio
Legend Capital is a subsidiary of Legend Holdings, managing $10B+ across roughly 600 companies since 2001. The firm is raising Fund VIII and Healthcare Fund II, targeting $1B+ each. The portfolio includes 12 unicorns, 54 IPOs, and 21 acquisitions including Didi, Baidu, and Pharmaron.
Focus areas span TMT, healthcare, consumption, enterprise services, and intelligent manufacturing. The firm prefer...
Notable Investments
P
PharmaronB
BaiduD
DidiSimilar Funds
CI
Cathay Innovation
Paris, France
GeneralistAIRoboticsMedtechSeedSeries A
D
DHVC
Palo Alto, California, United States
GeneralistAIBiotechMedtechSeedSeries A
LG Technology Ventures
Seoul, South Korea
GeneralistAIAdvanced MaterialsMedtechSeedSeries A
Vertex Holdings
Singapore
GeneralistAIBiotechMedtechSeedSeries A
B
Beringea
London, United Kingdom
GeneralistAIMedtechClimate TechSeries ASeries B+
Hearst Ventures
New York, United States
GeneralistAIMobilityIoT & EdgeSeries ASeries B+